Madrigal Pharmaceuticals (MDGL) Short Interest Ratio & Short Volume → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free MDGL Stock Alerts $194.38 -10.27 (-5.02%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Madrigal Pharmaceuticals Short Interest DataCurrent Short Volume3,410,000 sharesPrevious Short Volume3,360,000 sharesChange Vs. Previous Month+1.49%Dollar Volume Sold Short$788.97 millionShort Interest Ratio / Days to Cover5.9Last Record DateApril 15, 2024Outstanding Shares19,900,000 sharesPercentage of Shares Shorted17.14%Today's Trading Volume707,187 sharesAverage Trading Volume530,472 sharesToday's Volume Vs. Average133% Short Selling Madrigal Pharmaceuticals ? Sign up to receive the latest short interest report for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMDGL Short Interest Over TimeMDGL Days to Cover Over TimeMDGL Percentage of Float Shorted Over Time Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). Madrigal Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,410,000 shares $788.97 million +1.5%N/A5.9 $231.37 3/31/20243,360,000 shares $897.25 million +3.1%N/A6 $267.04 3/15/20243,260,000 shares $881.41 million -5.8%20.2%5.9 $270.37 2/29/20243,460,000 shares $817.25 million +2.1%21.4%7.3 $236.20 2/15/20243,390,000 shares $753.33 million +8.0%21.1%7.6 $222.22 1/31/20243,140,000 shares $680.47 million -5.1%19.5%7.2 $216.71 Get the Latest News and Ratings for MDGL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20243,310,000 shares $780.50 million +1.9%21.1%8.6 $235.80 12/31/20233,250,000 shares $751.99 million +5.9%20.7%7.9 $231.38 12/15/20233,070,000 shares $727.99 million -11.5%19.5%6.7 $237.13 11/30/20233,470,000 shares $705.45 million +0.3%24.4%7.1 $203.30 11/15/20233,460,000 shares $559.41 million +1.5%24.3%7.7 $161.68 10/31/20233,410,000 shares $448.01 million +13.3%24.7%8.2 $131.38 10/15/20233,010,000 shares $422.51 million +13.6%21.8%7.6 $140.37 9/30/20232,650,000 shares $387.01 million +24.4%19.2%7.4 $146.04 9/15/20232,130,000 shares $374.65 million +8.7%16.5%6.3 $175.89 8/31/20231,960,000 shares $352.80 million +8.3%15.2%6.3 $180.00 8/15/20231,810,000 shares $315.25 million -1.1%14.0%5.7 $174.17 7/31/20231,830,000 shares $375.70 million -3.2%13.8%5.3 $205.30 7/15/20231,890,000 shares $426.71 million +7.4%14.3%5.4 $225.77 6/30/20231,760,000 shares $406.56 million +10.0%13.3%4.7 $231.00 6/15/20231,600,000 shares $408.85 million +10.3%12.1%4.7 $255.53 5/31/20231,450,000 shares $403.69 million +15.1%10.4%3.9 $278.41 5/15/20231,260,000 shares $365.77 million -8.7%9.0%3.1 $290.29 4/30/20231,380,000 shares $430.56 million -6.8%10.0%3.3 $312.00 4/15/20231,480,000 shares $354.89 million +19.4%10.8%3.7 $239.79 3/31/20231,240,000 shares $300.40 million +3.3%9.2%3.1 $242.26 3/15/20231,200,000 shares $286.57 million +16.5%8.7%2.3 $238.81 2/28/20231,030,000 shares $279.14 million +9.2%7.4%1.6 $271.01 2/15/2023942,900 shares $266.14 million 0.0%7.2%1.5 $282.26 1/31/2023943,300 shares $271.91 million -3.3%7.2%1.6 $288.25 1/15/2023975,300 shares $292.57 million -12.9%7.5%1.6 $299.98 12/30/20221,120,000 shares $325.08 million -52.7%9.0%1.9 $290.25 12/15/20222,370,000 shares $149.07 million +9.7%19.1%4.3 $62.90 11/30/20222,160,000 shares $151.44 million +3.9%17.4%7.3 $70.11 11/15/20222,080,000 shares $146.68 million +14.3%16.8%7.9 $70.52 10/31/20221,820,000 shares $128.89 million +17.4%14.7%7.4 $70.82 10/15/20221,550,000 shares $100.27 million +1.3%12.5%6.6 $64.69 9/30/20221,530,000 shares $99.43 million +2.7%12.4%7.2 $64.99 9/15/20221,490,000 shares $103.70 million +1.4%12.1%7.4 $69.60 8/31/20221,470,000 shares $106.02 million -4.6%11.9%7.8 $72.12“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). MDGL Short Interest - Frequently Asked Questions What is Madrigal Pharmaceuticals' current short interest? Short interest is the volume of Madrigal Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 3,410,000 shares of MDGL short. Learn More on Madrigal Pharmaceuticals' current short interest. What is a good short interest ratio for Madrigal Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MDGL shares currently have a short interest ratio of 6.0. Learn More on Madrigal Pharmaceuticals's short interest ratio. Which institutional investors are shorting Madrigal Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Madrigal Pharmaceuticals: Simplex Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Madrigal Pharmaceuticals' short interest increasing or decreasing? Madrigal Pharmaceuticals saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 3,410,000 shares, an increase of 1.5% from the previous total of 3,360,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Madrigal Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Madrigal Pharmaceuticals: Alkermes plc (7.99%), Amicus Therapeutics, Inc. (10.60%), Ionis Pharmaceuticals, Inc. (7.12%), Rocket Pharmaceuticals, Inc. (12.15%), Geron Co. (9.04%), Dynavax Technologies Co. (14.17%), Ironwood Pharmaceuticals, Inc. (13.96%), Ligand Pharmaceuticals Incorporated (4.98%), MannKind Co. (13.21%), Y-mAbs Therapeutics, Inc. (7.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Madrigal Pharmaceuticals stock? Short selling MDGL is an investing strategy that aims to generate trading profit from Madrigal Pharmaceuticals as its price is falling. MDGL shares are trading down $10.27 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Madrigal Pharmaceuticals? A short squeeze for Madrigal Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MDGL, which in turn drives the price of the stock up even further. How often is Madrigal Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MDGL, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ALKS Short Interest FOLD Short Interest IONS Short Interest RCKT Short Interest GERN Short Interest DVAX Short Interest IRWD Short Interest LGND Short Interest MNKD Short Interest YMAB Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MDGL) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsThe World's First "$20 Trillion Drug?"Behind the MarketsI’m afraid WWIII is a very real possibility Porter & Company